{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:10:53Z","timestamp":1790539853158,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1111\/j.1523-1755.2004.00482.x","type":"journal-article","created":{"date-parts":[[2004,2,13]],"date-time":"2004-02-13T12:45:48Z","timestamp":1076676348000},"page":"1099-1104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":140,"title":["Nicotinamide suppresses hyperphosphatemia in hemodialysis patients"],"prefix":"10.1016","volume":"65","author":[{"given":"Yutaka","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Fukuwatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1973.92","article-title":"The role of phosphate restriction in the prevention of secondary hyperparathyroidism in chronic renal disease","volume":"4","author":"Slatopolsky","year":"1973","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0272-6386(12)80446-X","article-title":"Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease","volume":"19","author":"Delmez","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ki.1986.252","article-title":"The absorption of dietary phosphorus and calcium in hemodialysis patients","volume":"30","author":"Ramirez","year":"1986","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0272-6386(12)80882-1","article-title":"Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate","volume":"18","author":"Hou","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM197601222940402","article-title":"The dialysis encephalopathy syndrome. Possible aluminum intoxication","volume":"294","author":"Alfrey","year":"1976","journal-title":"N EngI J Med"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198209163071202","article-title":"The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy","volume":"307","author":"Ott","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198607173150304","article-title":"Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis","volume":"315","author":"Slatopolsky","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-6386(12)80059-X","article-title":"Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy","volume":"5","author":"Meric","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0050","first-page":"F447","article-title":"Nicotinamide restores phosphaturic effect of PTH and calcitonin in phosphate deprivation","volume":"242","author":"Berndt","year":"1982","journal-title":"Am J Physio1"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0055","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI110163","article-title":"Possible role of nicotinamide adenine dinucleotide as an intracellular regulator of renal transport of phosphate in the rat","volume":"67","author":"Kempson","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0060","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/ndt\/14.5.1195","article-title":"Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine","volume":"14","author":"Katai","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0065","first-page":"177","article-title":"Blood NAD as an index of niacin nutrition","volume":"2","author":"Siibata","year":"1986","journal-title":"Nutr Int"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0003-2697(69)90025-6","article-title":"A simple ultramicro method for determination of pyridine nucleotides in tissues","volume":"27","author":"Nisselbaum","year":"1969","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1525-1594.1997.tb00246.x","article-title":"New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations","volume":"21","author":"Shinzato","year":"1997","journal-title":"Artif Organs"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0272-6386(97)90009-3","article-title":"Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure","volume":"29","author":"Chertow","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0085","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/ndt\/13.9.2303","article-title":"Effect of RenaGel\u00ae, a non-absorbed, calcium- and alminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients","volume":"13","author":"Goldberg","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1523-1755.1999.00240.x","article-title":"Rena Gel\u00ae, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone","volume":"55","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0095","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","article-title":"A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients","volume":"33","author":"Bleyer","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/diacare.19.12.1357","article-title":"Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM","volume":"19","author":"Pozzilli","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0105","first-page":"F432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol","volume":"259","author":"Lopez-Hilker","year":"1990","journal-title":"Am J Physio1"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000188591","article-title":"Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: Possible direct role of phosphorus","volume":"70","author":"Yi","year":"1995","journal-title":"Nephron"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0115","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J CIin Invest"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0120","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/oxfordjournals.ndt.a027665","article-title":"A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells","volume":"11","author":"Nielsen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0125","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI109385","article-title":"Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism","volume":"63","author":"Shepherd","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ndt\/12.1.19","article-title":"Should hyperlipidaemia in dialysis patients be treated?","volume":"12","author":"Wheeler","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0135","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/039139889601901104","article-title":"Arteriosclerosis in dialysis patients","volume":"19","author":"Bommer","year":"1996","journal-title":"Int J Artif Organs"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0272-6386(96)90034-7","article-title":"Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis","volume":"27","author":"O'Neal","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.00482.x_bb0145","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s001250050362","article-title":"Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study)","volume":"38","author":"Pozzilli","year":"1995","journal-title":"Diabetologia"},{"issue":"Suppl 84","key":"10.1111\/j.1523-1755.2004.00482.x_bb0150","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1046\/j.1523-1755.63.s84.36.x","article-title":"N-methyl-2-pyridone-5-carboxamide: A novel uremic toxin?","volume":"63","author":"Rutkowski","year":"2003","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815498047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815498047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:39:30Z","timestamp":1758760770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815498047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0085253815498047"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00482.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00482.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}